Nektar Therapeutics (NKTR)
72.46
+0.01
(+0.01%)
USD |
NASDAQ |
Mar 06, 10:17
Nektar Therapeutics Market Cap : 1.254B for March 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rigel Pharmaceuticals, Inc. | 526.39M |
| Insmed, Inc. | 30.91B |
| Regeneron Pharmaceuticals, Inc. | 80.14B |
| Ironwood Pharmaceuticals, Inc. | 575.60M |
| Lyell Immunopharma, Inc. | 329.33M |
Market Cap Related Metrics
| PS Ratio | 74.72 |
| PEG Ratio | -0.0357 |
| Price to Book Value | 14.73 |
| Price | 72.46 |
| Earnings Yield | -6.29% |
| PEGY Ratio | -0.0357 |